Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Carr

Showing results (561-570 of 830) with videos related to

Pageof 83
Sort By:
Diabetes, Obesity & Metabolism|March 7, 2012
Reply to: Ahren B et al. Mechanisms of action of the dipeptidyl peptidase-4 inhibitor vildagliptin in humans. Diabetes Obes Metab 2011; 13(9): 775-783 and Ahren B et al. Clinical evidence and mechanistic basis for vildagliptin's action when added to metformin. Diabetes Obes Metab 2011; 13(3): 193-203R D Carr, H L Katzeff, C M Alexander, et al.
The Journal of Clinical Endocrinology and Metabolism|May 20, 2011
Incretin hormone and insulin responses to oral versus intravenous lipid administration in humansOla Lindgren, Richard D Carr, Carolyn F Deacon, et al.
The Journal of Biological Chemistry|August 15, 1998
High resolution structure of the N-terminal domain of tissue inhibitor of metalloproteinases-2 and characterization of its interaction site with matrix metalloproteinase-3F W Muskett, T A Frenkiel, J Feeney, et al.
Pediatric Transplantation|August 27, 2021
Domino transplantation for pediatric liver recipients: Obstacles, challenges, and successesVikram K Raghu, Peter D Carr-Boyd, James E Squires, et al.
British Journal of Pharmacology|May 1, 1990
Preferential biliary elimination of FPL 63547, a novel inhibitor of angiotensin-converting enzyme, in the ratR D Carr, A E Cooper, R Hutchinson, et al.
Ophthalmology|January 26, 1999
Complications of laser in situ keratomileusis for the correction of myopiaR D Stulting, J D Carr, K P Thompson, et al.
American Journal of Physiology. Endocrinology and Metabolism|July 10, 2008
Incretin and islet hormonal responses to fat and protein ingestion in healthy menRichard D Carr, Marianne O Larsen, Maria Sörhede Winzell, et al.
The Journal of Urology|November 11, 2005
Lymphovascular invasion is an independent prognostic factor in prostatic adenocarcinomaLiang Cheng, Timothy D Jones, Haiqun Lin, et al.
Archives of Biochemistry and Biophysics|May 21, 1999
Peroxyvanadium compounds inhibit glucose-6-phosphatase activity and glucagon-stimulated hepatic glucose output in the rat in vivoN Westergaard, C L Brand, R H Lewinsky, et al.
Journal of Forensic Sciences|June 16, 2000
Validation of the PowerPlex 1.1 loci for use in human identificationS A Greenspoon, P J Lytle, S A Turek, et al.
Pageof 83

Showing results (561-570 of 830) with videos related to

Sort By:
Pageof 83
Diabetes, Obesity & Metabolism|March 7, 2012
Reply to: Ahren B et al. Mechanisms of action of the dipeptidyl peptidase-4 inhibitor vildagliptin in humans. Diabetes Obes Metab 2011; 13(9): 775-783 and Ahren B et al. Clinical evidence and mechanistic basis for vildagliptin's action when added to metformin. Diabetes Obes Metab 2011; 13(3): 193-203R D Carr, H L Katzeff, C M Alexander, et al.
The Journal of Clinical Endocrinology and Metabolism|May 20, 2011
Incretin hormone and insulin responses to oral versus intravenous lipid administration in humansOla Lindgren, Richard D Carr, Carolyn F Deacon, et al.
The Journal of Biological Chemistry|August 15, 1998
High resolution structure of the N-terminal domain of tissue inhibitor of metalloproteinases-2 and characterization of its interaction site with matrix metalloproteinase-3F W Muskett, T A Frenkiel, J Feeney, et al.
Pediatric Transplantation|August 27, 2021
Domino transplantation for pediatric liver recipients: Obstacles, challenges, and successesVikram K Raghu, Peter D Carr-Boyd, James E Squires, et al.
British Journal of Pharmacology|May 1, 1990
Preferential biliary elimination of FPL 63547, a novel inhibitor of angiotensin-converting enzyme, in the ratR D Carr, A E Cooper, R Hutchinson, et al.
Ophthalmology|January 26, 1999
Complications of laser in situ keratomileusis for the correction of myopiaR D Stulting, J D Carr, K P Thompson, et al.
American Journal of Physiology. Endocrinology and Metabolism|July 10, 2008
Incretin and islet hormonal responses to fat and protein ingestion in healthy menRichard D Carr, Marianne O Larsen, Maria Sörhede Winzell, et al.
The Journal of Urology|November 11, 2005
Lymphovascular invasion is an independent prognostic factor in prostatic adenocarcinomaLiang Cheng, Timothy D Jones, Haiqun Lin, et al.
Archives of Biochemistry and Biophysics|May 21, 1999
Peroxyvanadium compounds inhibit glucose-6-phosphatase activity and glucagon-stimulated hepatic glucose output in the rat in vivoN Westergaard, C L Brand, R H Lewinsky, et al.
Journal of Forensic Sciences|June 16, 2000
Validation of the PowerPlex 1.1 loci for use in human identificationS A Greenspoon, P J Lytle, S A Turek, et al.
Pageof 83